Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CUSTOMI Arch

Financiado

Cerrado

New materials for revolutionary branched non supported stents CUSTOMI for a...

New materials for revolutionary branched non supported stents CUSTOMI for aortic arch endovascular repair Aortic dissection and aneurysms are the two most common life-threatening disorders affecting the aorta. Unless they are treated immediately, they result in shock and death in 80% of cases. However, according to Prof. Koskas, today... ver más

31/01/2017

ENDONOV SAS

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

ENDONOV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2017-01-31

SMEInst-02-2016-2017: Accelerating the uptake of nanotech...

I+D

Cerrada hace 9 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

ENDONOV SAS

50.00K€ | Lider

VIVEROS VILLANUEVA VIDES

326.99K€ | Participante

Proyectos interesantes

PID2021-124868OB-C22

Medical Technol...

Materials Scien...

94K€ Cerrado

AORTYX

Medical Technol...

Materials Scien...

71K€ Cerrado

STAAART SmarT Abdominal Aortic AneuRysm Treatment

Medical Technol...

Biomedical Engi...

4M€ Cerrado

Epeius

Medical Technol...

Materials Scien...

2M€ Cerrado

AORTYX

Medical Technol...

Materials Scien...

4M€ Cerrado

DISEÑO Y FABRICACIÓN DE PRÓTESIS INTRAVASCULA...

Medical Technol...

Materials Scien...

853K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 6 meses Fecha Inicio: 2016-07-11
Fecha Fin: 2017-01-31

Líder del proyecto

ENDONOV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Aortic dissection and aneurysms are the two most common life-threatening disorders affecting the aorta. Unless they are treated immediately, they result in shock and death in 80% of cases. However, according to Prof. Koskas, today up to 50% of patients with a high surgical risk cannot be treated with traditional open surgery. This implies that new and less invasive interventions are urgently needed. This is not only a European challenge, but a global one that impacts patients worldwide. Endonov is developing a disruptive solution called the CUSTOMI® Arch Branched stent system to overcome these existing problems. New woven fabric materials and advanced manufacturing procedures are playing a crucial role in CUSTOMI®’s unique design and fabrication. For the first time, smaller, tailor-made and multi-branched stent-grafts will be able to take the shape of the complex aortic arch anatomy of each patient. This medical device will be implanted and positioned with greater precision using an advanced sensor guided delivery system. This will allow to treat much more patients with different arch anatomies and ensure a longer term durability of the device. Endovascular surgeons from the famous US Mayo Clinic have stated CUSTOMI® Arch is currently the only solution in development able to overcome the major problem of complex aortic arch morphology and anatomy. Endovascular repair technology for the aortic arch is a highly growing and emerging field. Endonov has a huge opportunity to market a new medical device that will benefit thousands of patients all over the world, effectively lowering lethal rates of aortic arch pathologies. The commercialization of the CUSTOMI® Arch will make Endonov the first European company and a worldwide leader in the field of endovascular aortic repair with an estimated turnover of about 67 million euros and the creation of 71 new high-level jobs in Europe by 2022.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores